Platelet Function Analyzer-200 P2Y Results Are Predictive of the Risk of Major Adverse Cardiac Events in Korean Patients Receiving Clopidogrel Therapy Following Acute Coronary Syndrome

BACKGROUND: Clopidogrel is one of the most commonly used anti-platelet agents in cardiovascular diseases. We analyzed the relationship between the platelet function analyzer (PFA)-200 P2Y (INNOVANCE PFA-200 System, Siemens Healthcare, Germany) results and occurrence of major adverse cardiac events (...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Hyeon-Ho, Li, Shuhua, An, Gyu-Dae, Woo, Kwang-Sook, Kim, Kyeong-Hee, Kim, Jeong-Man, Kim, Moo-Hyun, Han, Jin-Yeong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society for Laboratory Medicine 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5973914/
https://www.ncbi.nlm.nih.gov/pubmed/29797810
http://dx.doi.org/10.3343/alm.2018.38.5.413

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5973914/
https://www.ncbi.nlm.nih.gov/pubmed/29797810
http://dx.doi.org/10.3343/alm.2018.38.5.413

Ejemplares similares